Breaking News Instant updates and real-time market news.

DVAX

Dynavax

$19.30

0.35 (1.85%)

06:46
05/17/18
05/17
06:46
05/17/18
06:46

Dynavax should trade to $21-$22 on abstract data, says JPMorgan

JPMorgan analyst Anupam Rama believes shares of Dynavax should trade up 5%-15% to the $21-$22 range on the SD-101 melanoma ASCO abstract. While some on the Street were inappropriately setting the benchmark at 70%-80% overall response, the abstract data "very much put the early efficacy signals" of SD-101 plus pembrolizumab in the ballpark of nivolumab plus ipilimumab from CHECKMATE-067, with a cleaner safety profile, Rama tells investors in a research note. He says the abstract met his "base case / win / upside scenario."

  • 12

    Jun

DVAX Dynavax
$19.30

0.35 (1.85%)

04/17/18
COWN
04/17/18
NO CHANGE
Target $30
COWN
Outperform
Dynavax shares remain undervalued, says Cowen
Cowen analyst Phil Nadeau noted Dynavax presented data from a Phase 1b/II study of its head and neck cancer trial which resulted in a ORR of 33%. The analyst continue to believe Dynavax shares are undervalued. Nadeau reiterated his Outperform rating and $30 price target on Dynavax shares.
04/17/18
WBLR
04/17/18
NO CHANGE
WBLR
Outperform
William Blair says SD-101 not in $40 fair estimate for Dynavax shares
Dynavax Technologies' data thus far in squamous cell carcinoma of the head and neck and melanoma are "compelling" and will see SD-101 "finally getting into" the stock as the Street comes to appreciate the oncology side of the business, William Blair analyst Y. Katherine Xu tells investors in a research note. She points out that SD-101, or Dynavax's other oncology assets, are not included in her $40 fair value estimate of the stock. These opportunities represent "significant upside to our valuation," Xu contends. The analyst keeps an Outperform rating on Dynavax. The stock closed yesterday at $18.85.
05/10/18
JPMS
05/10/18
UPGRADE
Target $27
JPMS
Overweight
Dynavax upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Anupam Rama upgraded Dynavax Technologies to Overweight and raised his price target for the shares to $27 from $25 following the company's Q1 results. The analyst believes TLR9 agonist SD-101 is an underappreciated asset.
05/10/18
JPMS
05/10/18
UPGRADE
Target $27
JPMS
Overweight
JPMorgan upgrades Dynavax on 'vastly underappreciated' SD-101
JPMorgan analyst Anupam Rama upgraded Dynavax Technologies to Overweight from Neutral and raised his price target for the shares to $27 from $25. While a Heplisav launch inflection in 2019 is widely expected, the company's SD-101 opportunity is being "vastly underappreciated" at current share levels, Rama tells investors in a research note. SD-101 has shown encouraging early signals of efficacy in both the melanoma and head and neck indications, the analyst contends. Rama points out that a Phase 2 melanoma update is expected next month at ASCO. He likes the stocks' reward/risk profile going into the readout. The analyst sees 30%-60% upside potential versus 0%-10% downside risk on the data.

TODAY'S FREE FLY STORIES

LRLCY

L'Oreal

$0.00

(0.00%)

12:17
11/19/18
11/19
12:17
11/19/18
12:17
Hot Stocks
L'Oreal appoints of Christophe Babule to succeed Christian Mulliez as CFO »

L'Oreal announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/19/18
11/19
12:17
11/19/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNMX

Aevi Genomics Medicine

$1.12

-0.04 (-3.45%)

12:16
11/19/18
11/19
12:16
11/19/18
12:16
Conference/Events
Aevi Genomics Medicine management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
11/19/18
11/19
12:16
11/19/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$21.82

-0.43 (-1.93%)

12:15
11/19/18
11/19
12:15
11/19/18
12:15
Options
Teva put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

PRT

PermRock Royalty Trust

$10.75

-1.3 (-10.79%)

12:00
11/19/18
11/19
12:00
11/19/18
12:00
Hot Stocks
PermRock Royalty Trust falls -10.9% »

PermRock Royalty Trust is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFX

Colfax

$23.54

-4.46 (-15.93%)

12:00
11/19/18
11/19
12:00
11/19/18
12:00
Hot Stocks
Colfax falls -15.9% »

Colfax is down -15.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

SPB

Spectrum Brands

$47.10

-12.26 (-20.65%)

12:00
11/19/18
11/19
12:00
11/19/18
12:00
Hot Stocks
Spectrum Brands falls -20.7% »

Spectrum Brands is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

ZAYO

Zayo Group

$25.98

2.285 (9.64%)

12:00
11/19/18
11/19
12:00
11/19/18
12:00
Hot Stocks
Zayo Group rises 9.8% »

Zayo Group is up 9.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

REN

Resolute Energy

$34.93

4.42 (14.49%)

12:00
11/19/18
11/19
12:00
11/19/18
12:00
Hot Stocks
Resolute Energy rises 14.7% »

Resolute Energy is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USO

United States Oil Fund

$11.95

-0.115 (-0.95%)

12:00
11/19/18
11/19
12:00
11/19/18
12:00
Options
35K US Oil Fund Jan 11 - 11.5 put spreads trade 16c on ISE »

35K US Oil Fund Jan 11 -…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UGAZ

VelocityShares 3x Long Natural Gas ETN

$175.00

23 (15.13%)

12:00
11/19/18
11/19
12:00
11/19/18
12:00
Hot Stocks
VelocityShares 3x Long Natural Gas ETN rises 16.1% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$78.22

-1.45 (-1.82%)

, AMZN

Amazon.com

$1,541.22

-52.37 (-3.29%)

11:59
11/19/18
11/19
11:59
11/19/18
11:59
Earnings
Fly Intel: What to watch in Target's earnings report »

Target (TGT) is scheduled…

TGT

Target

$78.22

-1.45 (-1.82%)

AMZN

Amazon.com

$1,541.22

-52.37 (-3.29%)

WMT

Walmart

$97.07

-0.63 (-0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 28

    Nov

  • 04

    Dec

  • 03

    Mar

WB

Weibo

$57.67

-1.6 (-2.70%)

11:55
11/19/18
11/19
11:55
11/19/18
11:55
Options
Weibo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

11:55
11/19/18
11/19
11:55
11/19/18
11:55
General news
More from Fed's Williams: U.S. employers are hiring less-skilled »

More from Fed's…

SNAP

Snap

$6.12

-0.37 (-5.70%)

, TWTR

Twitter

$32.44

-1.26 (-3.74%)

11:54
11/19/18
11/19
11:54
11/19/18
11:54
Conference/Events
FBN Securities social media/advertising analysts to hold group luncheon »

Analysts hold a Group…

SNAP

Snap

$6.12

-0.37 (-5.70%)

TWTR

Twitter

$32.44

-1.26 (-3.74%)

AMZN

Amazon.com

$1,539.71

-53.88 (-3.38%)

FB

Facebook

$132.94

-6.61 (-4.74%)

GOOG

Alphabet

$1,037.20

-24.81 (-2.34%)

IPG

Interpublic Group

$23.79

-0.26 (-1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 28

    Nov

  • 03

    Dec

  • 04

    Dec

  • 03

    Mar

11:52
11/19/18
11/19
11:52
11/19/18
11:52
Conference/Events
Stephens analyst to hold an analyst/industry conference call »

Analysts host weather…

AAPL

Apple

$186.58

-6.84 (-3.54%)

, FB

Facebook

$133.19

-6.36 (-4.56%)

11:51
11/19/18
11/19
11:51
11/19/18
11:51
OnTheFly
Fly Intel: Wall Street's top stories at midday »

Stocks opened in negative…

AAPL

Apple

$186.58

-6.84 (-3.54%)

FB

Facebook

$133.19

-6.36 (-4.56%)

NSANY

Nissan

$0.00

(0.00%)

REN

Resolute Energy

$35.00

4.49 (14.72%)

XEC

Cimarex Energy

$88.90

0.27 (0.30%)

NIO

NIO Inc.

$8.08

0.9 (12.53%)

CFX

Colfax

$23.67

-4.33 (-15.46%)

BX

Blackstone

$31.87

-0.61 (-1.88%)

SPB

Spectrum Brands

$47.25

-12.11 (-20.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 28

    Nov

  • 29

    Nov

  • 04

    Dec

11:47
11/19/18
11/19
11:47
11/19/18
11:47
Conference/Events
UBS alternative energy analyst to hold an analyst/industry conference call »

Alternative Energy…

CLF

Cleveland-Cliffs

$10.05

-0.25 (-2.43%)

11:45
11/19/18
11/19
11:45
11/19/18
11:45
Options
Cleveland-Cliffs call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:44
11/19/18
11/19
11:44
11/19/18
11:44
Conference/Events
RBC Capital healthcare services analyst to hold a group luncheon »

Group Luncheon, where…

11:42
11/19/18
11/19
11:42
11/19/18
11:42
Conference/Events
RBC Capital oil services analyst to hold a luncheon meeting »

Group Luncheon, where…

11:39
11/19/18
11/19
11:39
11/19/18
11:39
Conference/Events
RBC Capital banking analyst to hold a group luncheon »

Group Luncheon, where…

AIMT

Aimmune

$27.96

-1.65 (-5.57%)

11:37
11/19/18
11/19
11:37
11/19/18
11:37
Recommendations
Aimmune analyst commentary  »

Clinical profile of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 27

    Nov

  • 12

    Dec

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

11:37
11/19/18
11/19
11:37
11/19/18
11:37
General news
Bitcoin price falls below $5,000 for first time since last year »

Bitcoin prices have seen…

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.